Press release
PREMIER Biosoft International Releases version 7.50 of AlleleID
Palo Alto, California – September 15, 2009- PREMIER Biosoft International today announced the world wide release of AlleleID version 7.50. AlleleID will now enable xMAP® users to design strain differentiation assays. AlleleID employs a powerful algorithm to first align the sequences and then identify unique regions in each. The capture probes are located in these regions and then checked for multiplexing for use in bead based suspension arrays, based on Luminex's xMAP® technology.In addition to the above, single template assays are also supported wherein oligos are designed for rapid and high-throughput SNP genotyping assays, particularly useful for population studies. It enables use of pre-designed proven oligos and designs a multiplex set compatible with them, saving costs. Included is a database of MicroPlex xTAGs (formerly known as FlexMAP TAGs) for automatic addition of appropriate tags to Allele Specific Primer Extension (ASPE) primers. Users also have the option to tag them on their own.
“AlleleID is now available for xMAP® users identifying strains. We are committed to keeping pace with their needs by constantly adding advanced and powerful features to our products,” commented Kay Brown, V.P. Business Development and Marketing.
For details, please visit: http://www.premierbiosoft.com/bacterial-identification/realtime-PCR/luminex_xMAP.html
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft International Releases version 7.50 of AlleleID here
News-ID: 96838 • Views: …
More Releases for Allele
Allele to Release Point of Origin Remastered to All Digital Retailers
Allele Taps Rock Sun Records/Virgin Music Group to Release Their Landmark Album Point of Origin Remastered
Florida hard rock/alt-metal band Allele is proud to announce the upcoming release of Point of Origin Remastered, set to hit all major digital retailers via Rock Sun Records/Virgin Music Group. The band's classic debut album, originally released in 2005, has been given a whole new lease on life thanks to the skilled hand of Genius…
Cell Reprogramming Market May See a Big Move| Allele Biotech, Alstem, Stemcell T …
Archive Market Research published a new research publication on "Cell Reprogramming Market" with 230+ pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cell Reprogramming market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in the study…
Cell Reprogramming Market Set to Witness Significant Growth by 2023-2030: Allele …
This research report provides an overview and forecast of the Cell Reprogramming Market for the years 2023 to 2030, including product specifications, technological developments, and key manufacturers. The research explores market obstacles like market demand, market share for the industry, CAGR, current market trends, and competitive vendor strategies. The research identifies and manages the several Cell Reprogramming market growth factors needed for a successful operation. This report is…
Gene Editing Technology Market to See Booming Growth | CRISPR Therapeutics, Sigm …
The latest study released on the Global Gene Editing Technology Market by AMA Research evaluates market size, trend, and forecast to 2027. The Gene Editing Technology market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key…
Gene Editing Technology Market May See a Big Move : Major Giants Cellectics, Edi …
Latest released the research study on Global Gene Editing Technology Market, offers a detailed overview of the factors influencing the global business scope. Gene Editing Technology Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Gene Editing Technology Market. The study covers emerging…
Gene Editing Market 2025 | AstraZeneca, Cellectis, Editas Medicine, Dharmacon, Q …
Global Gene Editing Market: Snapshot
Gene editing or genome editing is the targeted insertion or modification of cells in living organism or cells and the method has come to occupy a crucial part of biomedical researches, constantly transforming various disciplines of life sciences. Over the past few years, continuous advancements in gene-editing technologies have led to the advent of several versatile methods, which have enabled investigators to introduce a number…
